In addition, although peripheral CD8 T cells were reduced in COVID-19, ARDS, an over-activation in the respiratory tract manifested by higher cytotoxicity activity and inflammatory response, might partially explain the severe immune injury observed in those patients [27]. This evidence concerns the gene CD8A and acute respiratory distress syndrome.